Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Gender-related differences in outcome after BMS or DES implantation in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: insights from the DESERT cooperation.

De Luca G, Verdoia M, Dirksen MT, Spaulding C, Kelbæk H, Schalij M, Thuesen L, Hoeven Bv, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Diaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone GW; DESERT Cooperation.

Atherosclerosis. 2013 Sep;230(1):12-6. doi: 10.1016/j.atherosclerosis.2013.05.024. Epub 2013 Jun 27.

PMID:
23958246
2.

Impact of diabetes on long-term outcome after primary angioplasty: insights from the DESERT cooperation.

De Luca G, Dirksen MT, Spaulding C, Kelbæk H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Diaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone GW; DESERT cooperation.

Diabetes Care. 2013 Apr;36(4):1020-5. doi: 10.2337/dc12-1507. Epub 2012 Dec 28.

3.

Impact of hypertension on clinical outcome in STEMI patients undergoing primary angioplasty with BMS or DES: insights from the DESERT cooperation.

De Luca G, Dirksen MT, Spaulding C, Kelbæk H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Diaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone GW; DESERT cooperation.

Int J Cardiol. 2014 Jul 15;175(1):50-4. doi: 10.1016/j.ijcard.2014.04.180. Epub 2014 Apr 26.

PMID:
24852835
4.

Time course, predictors and clinical implications of stent thrombosis following primary angioplasty. Insights from the DESERT cooperation.

De Luca G, Dirksen MT, Spaulding C, Kelbæk H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Diaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone GW; DESERT cooperation.

Thromb Haemost. 2013 Oct;110(4):826-33. doi: 10.1160/TH13-02-0092. Epub 2013 Jul 18.

PMID:
23864101
5.

Impact of age on long-term outcome after primary angioplasty with bare-metal or drug-eluting stent (from the DESERT cooperation).

De Luca G, Dirksen MT, Spaulding C, Kelbæk H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Diaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone GW; DESERT cooperation.

Am J Cardiol. 2013 Jul 15;112(2):181-6. doi: 10.1016/j.amjcard.2013.03.012. Epub 2013 May 7.

PMID:
23664294
6.

Comparison of drug-eluting stents to bare-metal stents in ST-elevation myocardial infarction in long-term follow-up.

Kübler P, Jankowska EA, Ferenc M, Ponikowski P, Banasiak W, Reczuch K.

Kardiol Pol. 2013;71(1):25-31.

8.

Safety and effectiveness of drug eluting stent in patients with ST elevation myocardial infarction undergoing primary angioplasty.

Romano M, Buffoli F, Tomasi L, Corrado L, Ferrari MR, Zanini R.

Catheter Cardiovasc Interv. 2008 May 1;71(6):759-63. doi: 10.1002/ccd.21529.

PMID:
18412066
9.
10.

Comparison between drug-eluting and bare metal stent on ST-elevation myocardial infarction outcome: should second-generation drug-eluting stent be preferred?

Giglioli C, Cecchi E, Vladi L, Stolcova M, Valente S, Meucci F, Baldereschi GJ, Chiostri M, Romano SM, Gensini GF, Barchielli A, Balzi D.

J Cardiol. 2014 Apr;63(4):296-301. doi: 10.1016/j.jjcc.2013.09.007. Epub 2013 Dec 22.

11.

Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).

Holmvang L, Kelbæk H, Kaltoft A, Thuesen L, Lassen JF, Clemmensen P, Kløvgaard L, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Tilsted HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Helqvist S.

JACC Cardiovasc Interv. 2013 Jun;6(6):548-53. doi: 10.1016/j.jcin.2012.12.129. Epub 2013 May 15.

12.

Long-term outcomes of drug-eluting versus bare-metal stent for ST-elevation myocardial infarction.

Wang L, Wang H, Dong P, Li Z, Wang Y, Duan N, Zhao Y, Wang S.

Arq Bras Cardiol. 2014 Jun;102(6):529-38. Epub 2014 Jun 6. Review. English, Portuguese.

13.

Impact of diabetes on long-term outcome in STEMI patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors and BMS or DES.

De Luca G, Sauro R, Varricchio A, Capasso M, Lanzillo T, Manganelli F, Mariello C, Siano F, Carbone G, Pagliuca MR, Rosato G, Di Lorenzo E.

J Thromb Thrombolysis. 2010 Aug;30(2):133-41. doi: 10.1007/s11239-009-0420-5.

PMID:
19921102
14.

Very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction: a 15-year single-center experience.

Brodie B, Pokharel Y, Fleishman N, Bensimhon A, Kissling G, Hansen C, Milks S, Cooper M, McAlhany C, Stuckey T.

JACC Cardiovasc Interv. 2011 Jan;4(1):30-8. doi: 10.1016/j.jcin.2010.11.004.

15.

The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial.

Sabaté M, Brugaletta S, Cequier A, Iñiguez A, Serra A, Hernádez-Antolín R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A, Vázquez N, Backx B, Serruys PW.

JACC Cardiovasc Interv. 2014 Jan;7(1):64-71. doi: 10.1016/j.jcin.2013.09.006. Epub 2013 Dec 11.

16.

Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.

De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Díaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Cortese G, Suryapranata H, Stone GW; Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation.

Arch Intern Med. 2012 Apr 23;172(8):611-21; discussion 621-2. doi: 10.1001/archinternmed.2012.758. Review.

PMID:
22529227
18.

Drug-eluting versus bare-metal stents in the treatment of patients with ST-segment elevation myocardial infarction.

Hannan EL, Racz M, Walford G, Holmes DR, Jones RH, Sharma S, Katz S, King SB 3rd.

JACC Cardiovasc Interv. 2008 Apr;1(2):129-35. doi: 10.1016/j.jcin.2008.01.006.

19.

Drug-eluting stents in patients with anterior STEMI undergoing primary angioplasty: a substudy of the DESERT cooperation.

De Luca G, Dirksen MT, Spaulding C, Kelbæk H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone GW.

Clin Res Cardiol. 2014 Sep;103(9):685-99. doi: 10.1007/s00392-014-0702-6. Epub 2014 Apr 1.

PMID:
24687617
20.

Gender differences in long-term outcome after primary percutaneous intervention for ST-segment elevation myocardial infarction.

Wijnbergen I, Tijssen J, van 't Veer M, Michels R, Pijls NH.

Catheter Cardiovasc Interv. 2013 Sep 1;82(3):379-84. doi: 10.1002/ccd.24800. Epub 2013 Apr 29.

PMID:
23553888

Supplemental Content

Support Center